EZH2 positivity in UCS was previously reported in a single effusion cytology specimen in one study [37], which investigated the utility of EZH2 as a single immunomarker in the diagnosis of metastatic carcinoma in effusion samples. This evidence concerns the gene EZH2 and metastatic carcinoma.